百龙创园: 持股5%以上的股东权益变动触及1%刻度的提示性公告

Core Viewpoint - The announcement details a change in the equity stake of major shareholders in Shandong Bailong Chuangyuan Biotechnology Co., Ltd, indicating a decrease from 10.00% to 8.98% in total shareholding, which does not trigger mandatory tender offer obligations [1][2]. Group 1: Shareholder Information - The major shareholder involved in the equity change is Qingdao Enfu Kaijin Venture Capital Fund Partnership (Limited Partnership) [1]. - The associated party, Jiaxing Enfu Kaijin Investment Partnership (Limited Partnership), also holds a stake in the company [1]. - Guo Enyuan is mentioned as another significant shareholder, maintaining a consistent shareholding of 696.70 million shares, representing 2.16% [2]. Group 2: Equity Change Details - The equity change occurred with a reduction of 1.02% in total shareholding, moving from 10.00% (3,230.87 million shares) to 8.98% (2,902.87 million shares) [2]. - The change in shareholding was executed through direct shareholding adjustments, with specific transactions occurring between May 20, 2025, and May 23, 2025 [2]. - The announcement confirms that this equity change does not affect the control of the company or its major shareholders [2].